App to support post-hospital care for people with multiple chronic conditions
Official title: Care Transitions App for Patients With Multiple Chronic Conditions
Run by Brigham and Women's Hospital · NCT06051058 · Data updated 2026-11-12
This trial will test a smartphone/tablet app to help people aged 55+ with heart failure, diabetes, or chronic kidney disease manage their care after leaving the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 798 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 8, 2024 |
| Main results expected | June 2027 |
| Study ends | December 2027 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06051058 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
English-speaking adults aged 55 or older with a Brigham PCP or appointment at participating Brigham locations who are hospitalized on a general medicine unit, discharged to home/home health/assisted living, and have heart failure, type 2 diabetes, or chronic kidney disease plus at least one other chronic condition are ideal candidates.
✕Probably not a fit
People admitted to specialty units (e.g., ICU, surgery, cardiology), non‑English speakers, pregnant or institutionalized individuals, those too ill or with severe cognitive impairment to use an app, or patients discharged too quickly are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will test the Care Transitions App, a digital tool designed for older adults with multiple chronic conditions discharged from an academic general medicine service. The app combines four modules: falls-reduction content; a digital post-discharge care plan with education, medications, follow-up appointments, and warning signs; condition-specific post-discharge plans for diabetes, heart failure, and chronic kidney disease; and a post-discharge report for patient notes, questions, and recovery goals. Eligible patients will be randomized to receive the app or usual discharge procedures and followed for outcomes such as readmissions, post-discharge adverse events, medication adherence, and completion of follow-up care. The study seeks to see if the app improves communication across inpatient and ambulatory teams and reduces common post-discharge risks for people living with multiple chronic conditions.
Why it matters
Potential benefit: If successful, the app could reduce hospital readmissions and post-discharge adverse events (like falls and medication problems) while improving patients' ability to follow recovery plans.
How similar studies have gone: Previous transitional-care programs and some digital post-discharge tools have shown modest reductions in readmissions and improved follow-up in selected groups, but comprehensive app-based multi-condition interventions like this are still relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (55+) with a Brigham PCP or appointment in one of the 15 locations discharging from a BWH general medicine unit * Discharging to home, home health care service or assisted living * Fluent in spoken English in patient or healthcare proxy * Patients with at least one of the conditions listed below + one additional chronic condition on the problem list. * Patient with heart failure on the problem list * Patient with type 2 diabetes on the problem list * Patient with chronic kidney disease on the problem list Exclusion Criteria: * Adult patients (55+) with Westwood, Pembroke, or Transition Clinic PCP admitted to ICU, OBGYN, Surgical, Cardiology, Oncology, Orthopedics, or other Specialty Unit * Pregnant * Prisoner, institutionalized individual or in police custody * Discharge planned within 3 hours of screening * Patient too ill to participate or with active psychosis/serious mental illness, delirium, or severe dementia * Not fluent in spoken English in patient and health proxy * Unlikely to be discharged to home * Lacks a device capable of accessing the app * Lack of a working telephone for 30-day follow-up
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Lipika Samal, MD, MPH — Brigham and Women's Hospital
- Study coordinator: Lipika Samal, MD, MPH
- Email: lsamal@bwh.harvard.edu
- Phone: 617-732-7063
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pharmacy-led intervention to improve medication adherence after hospital discharge
This study tests a pharmacy-led program to help low-income patients with multiple chronic conditions take their medications correctly after leaving the hospital.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Community-informed approaches to equitable heart failure care in primary care
This study tests whether engaging patients, caregivers, community health workers, and care teams can help Mayo Clinic develop equity-focused, practical care strategies for adults with congestive heart failure who face social challenges.
-
Somatic health screening for adults in psychiatric outpatient care
This program tries adding regular physical-health screening into psychiatric outpatient care to see if it helps detect and manage heart disease, lung disease, diabetes, and other conditions in adults with psychotic or affective disorders.
-
Cardiovascular, Kidney, and Metabolic Health Assessment with Patient Empowerment
This program will test whether an AI chatbot, large language model Copilot, and remote vital‑sign monitoring can help adults with diabetes, heart disease, or chronic kidney disease reduce their combined cardio‑kidney‑metabolic disease burden.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.